WILLIAMS AND JENSEN, PLLC for PFIZER
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Tax issues affecting the pharmaceutical industry including international tax. H.R. 4213, revenue proposals on international tax.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER W HATCHER | — |
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA New | — |
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
Health Issues HCR
Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization act ; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Prescription drug advertising; animal health; and Federal preemption for prescription drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| REBECCA ANDERSON | — |
| JENNY DIJAMES | — |
| DENIS DWYER | — |
| JACK STEVEN HART | — |
| CHRISTOPHER W HATCHER | — |
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA New | — |
| KARINA LYNCH | — |
| MELINDA M MAXFIELD | — |
| GEORGE OLSEN | — |
| PATRICK PETTEY | — |
| ANTHONY J RODA | — |
| JOYCE A ROGERS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.